Measles cases are surging — over 1,300 confirmed across the US as of July 2025 (CDC). As outbreaks grow, the role of the clinical laboratory has never been more critical. Join us for the upcoming webinar: "Measles Matters! Understanding the Outbreak and the Lab’s Critical Role.“ Explore how labs are responding and how diagnostics can drive effective outbreak management. Register here: https://hubs.li/Q03BQplL0 In the meantime, check out our recent blog discussing the importance of diagnostic testing for individuals with measles-associated symptoms or for those who are unvaccinated or immunocompromised. Learn more: https://hubs.li/Q03BQpMT0 #Diasorin #measles #diagnostics #diagnostictesting #measlesoutbreak #webinar #publichealth
Chi siamo
DiaSorin is an Italian multinational group, one of the leading hi-tech players in the in vitro diagnostics market and, in particular, in the immunodiagnostics and molecular diagnostics segments, with over 50 years of experience. Our Group, owned by DiaSorin S.p.A., consists of 24 Companies, 5 foreign branches, offices on the 5 Continents and 6 manufacturing facilities located in Italy, Germany, UK, USA and South Africa. We are present in more than 60 countries with our direct sales network, supported by an international network of over 100 independent distributors. We develop, manufacture and market a vast and innovative line of tests for the diagnosis of infectious diseases or hormonal disorders, specifically designed for hospital and private testing laboratories, with an offer embracing different clinical areas. With more than 2000 employees all over the world, and over 210 researchers, we focus our business on improving the health and quality of people’s lives, through high-quality diagnostic products. We count on everyone’s uniqueness, with their skill and talent sets, and it’s considered a fundamental element for the creation of a working environment of excellence, able to adapt to the needs of a constantly evolving market.
- Sito Web
-
http://www.diasorin.com/
Link esterno per Diasorin
- Settore
- Ricerca biotecnologica
- Dimensioni dell’azienda
- 1001 - 5000 dipendenti
- Sede principale
- Saluggia, VC
- Tipo
- Società privata non quotata
- Settori di competenza
- Healthcare, Biotechnology, In Vitro Diagnostic, Immunoassay, Molecular Diagnostic, Blood tests, GI Stool Testing, Vitamin D, Prenatal screening, Infectious Diseases e Life Science
Località
-
Principale
Ottieni indicazioni
Via Crescentino
Saluggia, VC 13040, IT
-
Ottieni indicazioni
11331 Valley View St
Cypress, California, California 90630-4717, US
-
Ottieni indicazioni
1951 Northwestern Avenue PO BOX 285
Stillwater, Minnesota 55082 - 0285, US
-
Ottieni indicazioni
12212 Technology Blvd
Austin, Texas 78727, US
Dipendenti presso Diasorin
Aggiornamenti
-
Explore the ins and outs of diagnostic stewardship in our new podcast series, “Beyond the Result: Customizing Infectious Disease Diagnostics for Better Care,” hosted by Angelo Rago, President of the Luminex division of Diasorin. In episode 1, “The Diagnostic Stewardship Revolution,” Angelo speaks with Dr. James Snyder from the University of Louisville Hospital to discuss how to create successful diagnostic stewardship programs, the use of prevalence data and past lab results to establish clear algorithms, and more. If you’re passionate about improving healthcare and diagnostics, “Beyond the Result” is the show for you! Listen to the first episode today: https://hubs.li/Q03BvX1Y0 #BeyondTheResult #Diagnostics #HealthcareInnovation #Diasorin
-
-
Instead of running full syndromic panels for every patient, laboratorians and clinicians can now create custom panels aligned with clinical guidelines, seasonality, and patient populations. Flexible respiratory testing can help: - reduce cost - enable providers to make diagnostic decisions based on their clinical expertise - tailor testing to patient needs Check out our recent blog, “A Flexible Model Is Necessary for Today’s Respiratory Testing,” which discusses these benefits and links to two of our recent whitepapers presenting real-world advantages of implementing a flexible testing model. Don’t let respiratory seasonal uncertainty lead to unnecessary over-testing. Visit our blog to learn more: https://hubs.li/Q03yDRy30 #PrecisionDiagnostics #LIAISONPLEX #SyndromicTesting #CustomPanels
-
-
Today is the last day of the ADLM 2025 Clinical Lab Expo. Stop by Diasorin's booth #1431 to learn how better immunodiagnostic and molecular diagnostics can lead to better patient care. Don’t miss this opportunity to connect, learn, and shape the future of diagnostics. If you were unable to attend the show or just want to learn more about our products, please visit our website: https://us.diasorin.com/en. We will see you at ADLM in Anaheim next year! #ADLM2025 #Immunodiagnostics #MolecularDiagnostics
-
-
Diasorin releases another strong quarter, with margin expansion and continued top-line momentum, confirming the FY 2025 guidance. Read more: https://lnkd.in/d5UKFtHU
-
-
We hope you enjoyed our in-booth presentations yesterday addressing the challenges that laboratories face every day. We will be presenting five new topics at booth # 1431 today: • 10:15 AM “The Comeback that Nobody Wanted: Measles 2025” with Bojana Rolic-Polic • 11:15 AM “Two Viruses, One Liver: Navigating Guidelines for the Diagnosis of HBV and HDV Coinfection” with Ajay Grover, PhD, BCMAS, HCLD(ABB) • 1:15 PM “Analytical and Clinical Performance Evaluation of a Novel Host Protein based Assay for Patients with Suspected Respiratory Tract Infections” with He Sarina Yang, PhD, MBBS, DABCC (CC,TC) • 2:15 PM “Critical Conditions Deserve Smarter Solutions: Introducing the LIAISON PLEX® Bloodstream Infection Portfolio” with Michelle Tabb, PhD Learn more about our comprehensive suite of products: https://us.diasorin.com/en. #ADLM
-
-
The doors to the ADLM 2025 Clinical Lab Expo in Chicago open today. Stop by Booth #1431 today for our short, informative, and engaging in-booth presentations: • 10:15 AM “Potential Impact of Flexible Respiratory Testing: Clinical and Economical Benefit” with Bridget Parsons • 11:15 AM “Critical Conditions Deserve Smarter Solutions: Introducing the LIAISON PLEX® Bloodstream Infection Portfolio” with Michelle Tabb, PhD • 1:15 PM “Evaluation of the Analytical Performance of the LIAISON® MeMed BV® Assay at a Tertiary Cancer Center” with Esther Babady, PhD, D(ABMM) • 2:15 PM “Real-World Laboratory Workflow Improvements with LIAISON® Consolidation and Automation” with Ruel N. Del Rosario, MSHSA, MT (ASCP) • 3:15 PM “From Colonization to Invasive Disease: Future-Ready Diagnostics for Managing Fungal Infections” with Kaisha Gonzalez, PhD Learn more about our products: https://us.diasorin.com/en. #ADLM2025
-
-
Today, on World Hepatitis Day, we stand alongside the global community to raise awareness and accelerate action against viral hepatitis. At Diasorin, we are committed to supporting early detection and accurate diagnosis through advanced testing solutions - because every step toward awareness is a step toward elimination. #Diasorin #WorldHepatitisDay #EliminateHepatitis
-
-
Stop by booth #1431 at ADLM 2025 (Association for Diagnostics & Laboratory Medicine) for our in-booth presentations led by top scientific experts, covering topics from bloodstream infections and measles resurgence to fungal diagnostics and respiratory testing innovations. Molecular topics include: • The LIAISON PLEX® bloodstream infection portfolio • Ongoing measles outbreaks • Future-ready diagnostics for managing fungal infections • Clinical and economic benefits of flexible respiratory testing Let’s shape the future of diagnostics together. Visit our website for a list of both molecular and immunodiagnostic sessions: https://hubs.li/Q03yrpQ-0 We hope to see you there! #ADLM2025 #Diagnostics #PatientCare #InfectiousDiseases #Diasorin
-
-
We’re excited to be part of ADLM 2025 Clinical Lab Expo (Association for Diagnostics & Laboratory Medicine) and invite you to stop by booth #1431 for a series of insightful molecular and immunodiagnostic in-booth presentations to be held Tuesday, July 29 – Wednesday, July 30. If you’re eager to learn how better diagnostics can lead to better patient care, then these sessions are for you! Don’t miss this opportunity to connect, learn, and shape the future of diagnostics with us. Visit our website for our full list of sessions: https://hubs.li/Q03yrpPT0 #ADLM2025 #Diagnostics #PatientCare #InfectiousDiseases #Diasorin
-